Press Release Hub logo
  • Submit a Release
  • Home
  • All
  • ESG
  • Health
  • Technology
  • Finance
  • Contributors

Business Wire

Business Wire

Business Wire is the global leader in news release distribution and regulatory disclosure. Business Wire delivers news and multimedia directly into editorial systems and leading online news platforms and is a trusted source for news organisations, journalists, investment professionals and regulatory authorities.

Results: 17389-17400 of 20572

Business Wire logo

bit.bio Announces First Project Within Multi-Year Collaboration Agreement with The Michael J. Fox Foundation (MJFF) to Generate Human Cell Products for Research and Drug Discovery in Parkinson’s disease

Patent Technology for Heat Dissipation LED Package (Graphic: Seoul Semiconductor Co., Ltd.)

Seoul Semiconductor Files Patent Infringement Lawsuit against Amazon in the European Unified Patent Court

Business Wire logo

J.P. Morgan Becomes Principal Member of Cartes Bancaires CB, France’s Leading Payment Network

Business Wire logo

Fujirebio Europe Expands Its Portfolio With Introduction of the Innovative PreCursor-M AnoGYN assay (RUO) for Methylation Testing in Anal Specimens

Business Wire logo

HCLTech Launches AI Force to Accelerate Time-to-Value in Software Development and Engineering Lifecycle

Business Wire logo

L&T Technology Services collaborates with Intel to scale Edge-AI solutions

MethaneSAT (Photo: Business Wire)

MethaneSAT Now in Orbit after SpaceX Launches Groundbreaking Mission to Protect the Climate

Business Wire logo

LivaNova Announces Proposed Private Offering of $300 Million of Convertible Senior Notes

David Ford, Chief People Officer, Prothena (Photo: Business Wire)

Prothena Appoints David Ford to Newly Created Chief People Officer Position

Pacific Defense Distributed Battlefield Sensors (Graphic: Business Wire)

Pacific Defense Awarded USN Contract to Advance AI and ML enabled EW systems for Multi-Mission, Multi-platform applications

Assured Guaranty Hires Melissa Gribble to Lead Business Development in Australia

Business Wire logo

ViiV Healthcare presents phase I clinical trial findings of a cabotegravir long-acting injectable investigational formulation allowing at least four months between doses

  • Prev Page
  • 1
  • 2
  • …
  • 1449
  • 1450
  • 1451
  • …
  • 1714
  • 1715
  • Next Page

Pages

  • Home
  • All
  • ESG
  • Health
  • Technology
  • Finance
  • Contributors

Press Release Hub

  • Our Services
  • Submit a Release

Websites

  • PA Media Group
  • PA Mediapoint
  • Distribution Packages

© PA Media Group. 2026

Terms of Use

Privacy Policy

Contact Us